BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11841485)

  • 1. Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction.
    Tazi-Ahnini R; Cox A; McDonagh AJ; Nicklin MJ; di Giovine FS; Timms JM; Messenger AG; Dimitropoulou P; Duff GW; Cork MJ
    Eur J Immunogenet; 2002 Feb; 29(1):25-30. PubMed ID: 11841485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 receptor antagonist allele 2 and familial alopecia areata.
    Barahmani N; de Andrade M; Slusser J; Zhang Q; Duvic M
    J Invest Dermatol; 2002 Feb; 118(2):335-7. PubMed ID: 11841553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of IL1A and IL1B variants in alopecia areata.
    Tazi-Ahnini R; McDonagh AJ; Cox A; Messenger AG; Britton JE; Ward SJ; Båvik CO; Duff GW; Cork MJ
    Heredity (Edinb); 2001 Aug; 87(Pt 2):215-9. PubMed ID: 11703512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of interleukin-1 receptor antagonist and interleukin-1β single-nucleotide polymorphisms C-511T and C+3953T in alopecia areata: susceptibility and severity association.
    Alfadhli S; Nanda A
    Clin Exp Med; 2014 May; 14(2):197-202. PubMed ID: 23584371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities.
    Barton JL; Herbst R; Bosisio D; Higgins L; Nicklin MJ
    Eur J Immunol; 2000 Nov; 30(11):3299-308. PubMed ID: 11093146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
    Shu KH; Lee SH; Cheng CH; Wu MJ; Lian JD
    Kidney Int; 2000 Aug; 58(2):783-9. PubMed ID: 10916103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome.
    Witkin SS; Vardhana S; Yih M; Doh K; Bongiovanni AM; Gerber S
    Am J Obstet Gynecol; 2003 Nov; 189(5):1413-7. PubMed ID: 14634579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
    Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
    Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of IL-1beta, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome.
    Kim SD; Park JM; Kim IS; Choi KD; Lee BC; Lee SH; Hong SJ; Jin SY; Lee HJ; Hong MS; Chung JH; Lee TW; Ihm CG; Cho BS
    Pediatr Nephrol; 2004 Mar; 19(3):295-9. PubMed ID: 14758530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene.
    Lind H; Zienolddiny S; Ryberg D; Skaug V; Phillips DH; Haugen A
    Lung Cancer; 2005 Dec; 50(3):285-90. PubMed ID: 16126303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro.
    Santtila S; Savinainen K; Hurme M
    Scand J Immunol; 1998 Mar; 47(3):195-8. PubMed ID: 9519856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study.
    Korthagen NM; van Moorsel CH; Kazemier KM; Ruven HJ; Grutters JC
    Immunogenetics; 2012 May; 64(5):371-7. PubMed ID: 22322675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.
    Vamvakopoulos J; Green C; Metcalfe S
    Eur J Immunol; 2002 Oct; 32(10):2988-96. PubMed ID: 12355453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy.
    Watanabe M; Iwano M; Akai Y; Kurioka H; Nishitani Y; Harada K; Hamano K; Shiiki H
    Nephron; 2002 Aug; 91(4):744-6. PubMed ID: 12138282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on bipolar disorder.
    Rafiei A; Hosseini SH; Taheri M; Hosseni-khah Z; Hajilooi M; Mazaheri Z
    Neuropsychobiology; 2013; 67(2):116-21. PubMed ID: 23406623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of interleukin-1 receptor antagonist gene polymorphism on disease.
    Witkin SS; Gerber S; Ledger WJ
    Clin Infect Dis; 2002 Jan; 34(2):204-9. PubMed ID: 11740709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype.
    Ramírez-Pérez S; De la Cruz-Mosso U; Hernández-Bello J; Martínez-Bonilla GE; Ramírez-Dueñas MG; Pereira-Suárez AL; Parra Rojas I; Martínez-López E; Macías-Barragán J; Muñoz-Valle JF
    Autoimmunity; 2017 Dec; 50(8):468-475. PubMed ID: 29226727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis.
    Feakes R; Sawcer S; Broadley S; Coraddu F; Roxburgh R; Gray J; Clayton D; Compston A
    J Neuroimmunol; 2000 Jun; 105(1):96-101. PubMed ID: 10713369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy.
    Tolusso B; Pietrapertosa D; Morelli A; De Santis M; Gremese E; Farina G; Carniello SG; Del Frate M; Ferraccioli G
    Pharmacogenomics; 2006 Jul; 7(5):683-95. PubMed ID: 16886894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.